MYGN

Myriad GeneticsA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Current thesis

Composite grade A from latest DB weights. Momentum 87.9 / Value 41.1

Posture

Constructive

Lead driver

Momentum

What changed

Momentum remains the lead driver in the composite, 7D delta -4.0.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

— · Net —

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade A · Constructive

Confidence Medium · Net —

Target $6.38

Why

Momentum88 · Δ7d -4.0

Value41 · Δ7d -0.1

SentimentN/A · Δ7d -

So what

Strength-led posture. Favor watchlist adds and disciplined entries.

Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits

Lead driver: Momentum · See technicals

Momentum

40% active weight

Current posture

7d trendSoftening

Δ7d

-4.0

Δ21d

+16.8

Value

60% active weight

Current posture

7d trendFlat

Δ7d

-0.1

Δ21d

0.0

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade A. Momentum 87.9 / Value 41.1

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$583.69M

Beta

1.90

Shares Out

94.45M

P/E (TTM) · Derived

-1.6

P/S (TTM)

0.69

P/FCF (TTM) · Derived

-43.31

Rev YoY

+2.3%

EPS YoY

+32981.8%

Gross Margin

+66.1%

Op Margin

-51.0%

Net Debt

$60.2M

Current Ratio

2.40

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology